LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIA
- 1 May 1974
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 232 (1), 201-210
- https://doi.org/10.1111/j.1749-6632.1974.tb20586.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- PRESENT KNOWLEDGE OF ASCORBIC ACID (VITAMIN C)Published by Oxford University Press (OUP) ,2009
- The Susceptibility to Autoxidation of Human Red Cell Lipids in Health and DiseaseBritish Journal of Haematology, 1972
- MEASUREMENT OF LIVER-IRON CONCENTRATION IN NEEDLE-BIOPSY SPECIMENSThe Lancet, 1971
- The Effect of Ascorbic Acid Deficiency on Desferrioxamine‐Induced Urinary Iron ExcretionBritish Journal of Haematology, 1969
- Clinical and Laboratory Studies on the Action of DesferrioxamineBritish Journal of Haematology, 1969
- Effects of Iron Overload on Ascorbic Acid MetabolismBMJ, 1968
- Improved automated technique for the estimation of iron in ferrioxamineJournal of Clinical Pathology, 1967
- Differential ferrioxamine test for measuring chelatable body ironJournal of Clinical Pathology, 1965
- Studies on Congenital Hemolytic Syndromes. IV. Gastrointestinal Absorption of IronBlood, 1962
- Siderosis in the BantuBMJ, 1962